表紙
市場調查報告書

疫苗佐劑市場:佔有率,規模,趨勢,行業分析和細分市場預測(2020-2027)

Vaccine Adjuvants Market Share, Size, Trends, Industry Analysis Report, By Product Type ; By Route of Administration ; By Disease Types; By Application, By Regions; Segment Forecast, 2020 -2027

出版商 Polaris Market Research 商品編碼 953081
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
疫苗佐劑市場:佔有率,規模,趨勢,行業分析和細分市場預測(2020-2027) Vaccine Adjuvants Market Share, Size, Trends, Industry Analysis Report, By Product Type ; By Route of Administration ; By Disease Types; By Application, By Regions; Segment Forecast, 2020 -2027
出版日期: 2020年06月01日內容資訊: 英文 110 Pages
簡介

到2027年,全球疫苗佐劑市場規模預計將達到13.57億美元。佐劑定義為與疫苗結合可激活抗原特異性免疫應答的物質,該抗原特異性免疫應答可增強給予任何個體的商業疫苗的特異性和免疫原性。佐劑可增強疫苗增強對某些傳染病的免疫力的功效。它通過模仿病原體相關的分子模式(PAMP)(例如脂多醣,脂質體,細菌細胞壁和內吞的未甲基化核酸)來引發陽性免疫反應。佐劑可以多種方式對疫苗產生有益作用。例如,提高掌握更高的免疫原性的效力,減少重複接種的次數,減少抗原的劑量,擴大個體的抗體應答以及誘導T細胞應答。

全球市場受到近期傳染病激增,廣泛的疫苗研究和政府資助的推動。通過歐盟Horizo□□n 2020計劃,歐盟(ENOVA)形成了ENOVA,即疫苗佐劑網絡。這將使行業專家和利益相關者都可以在疫苗研發和輔助研究領域工作,以減少新型疫苗的副作用和功效。

該報告調查和分析了全球疫苗佐劑市場,並提供了有關市場概況,按細分市場,競爭狀況和主要公司的市場分析的系統信息。

目錄

第1章簡介

  • 報告概述
    • 調查目的
    • 市場範圍
    • 先決條件
  • 利益相關者

第2章執行摘要

  • 市場亮點

第3章調查方法

  • 概述
    • 數據挖掘
  • 數據源
    • 主要來源
    • 次要來源

第4章疫苗佐劑市場的考慮

  • 行業快照
  • 市場動態
    • 增長因素和機遇
    • 壓制因素和挑戰
  • 波特的五力分析
  • 農藥分析
  • 市場行業趨勢

第5章按產品類型進行的市場評估

  • 主要發現
  • 簡介
    • 2016-2027年全球疫苗佐劑市場按產品類型劃分(百萬美元)
  • 基於礦鹽的佐劑
    • 全球疫苗佐劑市場,按礦物質鹽為主的佐劑,按地區分列,2016-2027年(百萬美元)
  • tenso活性佐劑
    • Tensoactive佐劑的全球疫苗佐劑市場,按地區分列,2016-2027年(百萬美元)
  • 助劑乳液
    • 全球疫苗佐劑市場,按佐劑乳液分類,按地區,2016-2027年(百萬美元)
  • 脂質體佐劑
    • 全球脂肪佐劑市場,按脂質體佐劑分類,按地區,2016-2027年(百萬美元)
  • 碳水化合物佐劑
    • 全球疫苗佐劑市場,按碳水化合物佐劑分類,按地區,2016-2027年(百萬美元)
  • 細菌來源的佐劑
    • 全球疫苗佐劑市場,按細菌佐劑,按地區,2016-2027年(百萬美元)
  • 類病毒顆粒(VLP)
    • 全球疫苗佐劑市場,按病毒樣顆粒(VLP)分地區,2016-2027年(百萬美元)
  • 其他類型
    • 2016-2027年按地區分列的全球其他疫苗佐劑市場(百萬美元)

第6章按管理路線劃分的市場

  • 主要發現
  • 簡介
    • 2016-2027年全球疫苗佐劑市場的管理途徑(百萬美元)
  • 口服
    • 全球疫苗佐劑市場,按口服,按地區,2016-2027年(百萬美元)
  • 皮下
    • 2016-2027年全球皮下疫苗佐劑市場(按地區)(百萬美元)
  • 鼻腔內
    • 全球疫苗佐劑市場,按鼻腔分佈,按地區分列,2016-2027年(百萬美元)
  • 肌肉內
    • 2016-2027年按地區分列的全球肌肉佐劑市場(百萬美元)
  • 皮內
    • 全球疫苗佐劑市場,按皮膚,按地區,2016-2027年(百萬美元)
  • 其他
    • 全球疫苗佐劑市場,其他,按地區,2016-2027年(百萬美元)

第7章按疾病類型劃分的市場

  • 主要發現
  • 簡介
    • 2016-2027年按疾病類型分列的全球疫苗佐劑市場(百萬美元)
  • 傳染病
    • 全球疫苗佐劑市場,按傳染病分區域,2016-2027(百萬美元)
  • 罕見疾病
    • 2016-2027年按地區分列的罕見病全球疫苗佐劑市場(百萬美元)
  • 癌症
    • 全球疫苗佐劑市場,按癌症分地區,2016-2027年(百萬美元)
  • 自身免疫性疾病
    • 全球免疫佐劑市場,按自身免疫病分區域,2016-2027年(百萬美元)
  • 其他
    • 全球疫苗佐劑市場,其他,按地區,2016-2027年(百萬美元)

第8章按應用評估市場

  • 主要發現
  • 簡介
    • 2016-2027年全球疫苗佐劑市場應用分佈(百萬美元)
  • 調查使用
    • 全球疫苗佐劑市場,按研究用途,按地區,2016-2027年(百萬美元)
  • 商業用途
    • 全球疫苗佐劑市場,按商業用途分地區,2016-2027年(百萬美元)

第9章按地區進行市場評估

  • 主要發現
  • 簡介
    • 疫苗佐劑市場評估,按地區,2016-2027年(百萬美元)
  • 北美
    • 按產品類型劃分,2016-2027年(百萬美元)
    • 按行政途徑劃分,2016-2027年(百萬美元)
    • 2016-2027年按疾病類型分(百萬美元)
    • 按應用,2016-2027年(百萬美元)
    • 美國
    • 加拿大
  • 歐洲
    • 按產品類型劃分,2016-2027年(百萬美元)
    • 按行政途徑劃分,2016-2027年(百萬美元)
    • 2016-2027年按疾病類型分(百萬美元)
    • 按應用,2016-2027年(百萬美元)
    • 英國
    • 法國
    • 德國
    • 意大利
    • 西班牙
    • 比利時
    • 奧地利
  • 亞太地區
    • 按產品類型劃分,2016-2027年(百萬美元)
    • 按行政途徑劃分,2016-2027年(百萬美元)
    • 2016-2027年按疾病類型分(百萬美元)
    • 按應用,2016-2027年(百萬美元)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 韓國
    • 澳大利亞
  • 中東/非洲
    • 按產品類型劃分,2016-2027年(百萬美元)
    • 按行政途徑劃分,2016-2027年(百萬美元)
    • 2016-2027年按疾病類型分(百萬美元)
    • 按應用,2016-2027年(百萬美元)
    • 沙特阿拉伯
    • 阿聯酋
    • 以色列
    • 南非
  • 拉丁美洲
    • 按產品類型劃分,2016-2027年(百萬美元)
    • 按行政途徑劃分,2016-2027年(百萬美元)
    • 2016-2027年按疾病類型分(百萬美元)
    • 按應用,2016-2027年(百萬美元)
    • 墨西哥
    • 巴西
    • 阿根廷

第10章競爭情況

  • 擴張和收購分析
    • 擴張
    • 收購
  • 夥伴關係/合作/合同/展覽

第11章公司簡介

  • GlaxoSmithKline Plc
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • Moderna Inc.
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • Sanofi Pasteur
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • Adjuvatis
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • SPI Pharma
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • Novavax,Inc.
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • Sergeant Adjuvants
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • OZ Biosciences
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • Adjuvants Euclid Canada Inc.
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • Adjuvants Unlimited Inc.
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
  • Aphios Corporation
    • 公司簡介
    • 產品基準測試
    • 財務狀況
    • 最新趨勢
目錄
Product Code: PM1684

Title:
Vaccine Adjuvants Market Share, Size, Trends, Industry Analysis Report, By Product Type (Mineral Salt-based Adjuvant, Tensoactive Adjuvants, Adjuvant Emulsions, Liposome Adjuvants, Carbohydrate Adjuvants, Bacteria-derived Adjuvants, Virus-like Particles (VLP), and Other Types); By Route of Administration (Oral, Subcutaneous, Intranasal, Intramuscular, Intradermal, and Others); By Disease Types; By Application (Research Application and Commercial Application), By Regions; Segment Forecast, 2020 -2027.

The global Vaccine Adjuvants Market size is expected to reach USD 1,305.7 million by 2027 according to a new study by Polaris Market Research. The report "Vaccine Adjuvants Market Share, Size, Trends, Industry Analysis Report, By Product Type (Mineral Salt-based, Tensoactive, Emulsions, Liposome, Carbohydrate, Bacteria-derived, Virus-like Particles (VLP), and Other Adjuvants); By Route of Administration (Oral, Subcutaneous, Intranasal, Intramuscular, Intradermal, and Others); By Disease Types (Infectious Diseases, Rare Diseases, Cancer, Autoimmune Disorders, and Others); By Application (Research Application and Commercial Application), By Regions; Segment Forecast, 2020 -2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Adjuvant is defined as a substance which in combination with vaccine invigorates antigen specific immune reactions to increase specificity and immunogenicity of marketed vaccines administered in any individual. Adjuvants augment the impact of a vaccine providing increased immunity towards any particular infectious disease. It triggers positive immune response by mimicking pathogen associated molecular pattern (PAMP), which include lipo-polysaccharide, liposomes, cell walls of bacteria, and endo-cytosed and un-methylated nucleic acids. Adjuvant imparts beneficial effects to vaccines in several ways such as increasing its potency to grasp the higher degree of immunogenicity, reducing the number of repeated vaccinations, antigen dose reduction, widening antibody responses of the individual, and inducing T-cell responses.

The global market is driven by the recent surge in infectious diseases, extensive research on vaccines, and funding from the government. European Union (EU) through EU programme Horizon 2020, has formed ENOVA, a network on vaccine adjuvants. This will bring both industry experts and stakeholders working in the areas of vaccine research and development and adjuvant research to reduce side effects and efficacy of new developing vaccines.

Market participants such as GlaxoSmithKline Plc, Novavax, Inc., Statens Serum Institut, Viscogel AB, VaxLiant LLC, Aphios Corporation, Moderna Inc., Sanofi Pasteur, Adjuvatis, Avanti Polar Lipids, Inc., MPV Technologies, CSL Limited, Vaxine Pty Ltd, SPI Pharma, CureVac AG, Sergeant Adjuvants, Agenus, Inc., OZ Biosciences, Adjuvants Unlimited Inc., and Adjuvants Euclid Canada Inc. are some of the key players operating in the concerned market.

To speed up the process of nCOV vaccine development big players are collaborating with industry stakeholders. In February 2020, GSK and Coalition for Epidemic Preparedness Innovations (CEPI) collaborated to ease the out nCOV vaccine development with GSK's vaccine adjuvant platform for other players in vaccine development. Similarly, in March 2020, iBio, a contract research organization (CRO) signed a definitive agreement with the Infectious Disease Research Institute (IDRI). The combination of iBio's VLP antigen with the latter adjuvant expected to offer promising efficacy and safety characteristics.

Polaris Market research has segmented the Vaccine Adjuvants Market report on the basis of product type, route of administration, disease type, application, and region

Vaccine Adjuvant Product Type Outlook (Revenue - USD Million, 2016 - 2027)

Mineral Salt-based Adjuvant

Tensoactive Adjuvants

Adjuvant Emulsions

Liposome Adjuvants

Carbohydrate Adjuvants

Bacteria-derived Adjuvants

Virus-like Particles (VLP)

Other Types

Vaccine Adjuvant Route of Administration Outlook (Revenue - USD Million, 2016 - 2027)

Oral

Subcutaneous

Intranasal

Intramuscular

Intradermal

Others

Vaccine Adjuvant Disease Type Outlook (Revenue - USD Million, 2016 - 2027)

Infectious Diseases

Rare Diseases

Cancer

Autoimmune Disorders

Others

Vaccine Adjuvant Application Outlook (Revenue - USD Million, 2016 - 2027)

Research Application

Commercial Application

Vaccine Adjuvant Regional Outlook (Revenue - USD Million, 2016 - 2027)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Belgium

Austria

Asia Pacific

China

India

Japan

Malaysia

Australia

South Korea

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Vaccine Adjuvants Market Insights

  • 4.1. Vaccine Adjuvant - Industry snapshot
  • 4.2. Vaccine Adjuvants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Surge in the infectious diseases
      • 4.2.1.2. Government sponsored immunization programs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side effects associated with the usage of adjuvants
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Vaccine Adjuvants Market Industry trends

5. Vaccine Adjuvants Market Assessment by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • 5.3. Mineral Salt-based Adjuvant
    • 5.3.1. Global Vaccine Adjuvants Market, by Mineral Salt-based Adjuvant, by Region, 2016- 2027 (USD Million)
  • 5.4. Tensoactive Adjuvants
    • 5.4.1. Global Vaccine Adjuvants Market, by Tensoactive Adjuvants, by Region, 2016- 2027 (USD Million)
  • 5.5. Adjuvant Emulsions
    • 5.5.1. Global Vaccine Adjuvants Market, by Adjuvant Emulsions, by Region, 2016- 2027 (USD Million)
  • 5.6. Liposome Adjuvants
    • 5.6.1. Global Vaccine Adjuvants Market, by Liposome Adjuvants, by Region, 2016- 2027 (USD Million)
  • 5.7. Carbohydrate Adjuvants
    • 5.7.1. Global Vaccine Adjuvants Market, by Carbohydrate Adjuvants, by Region, 2016- 2027 (USD Million)
  • 5.8. Bacteria-derived Adjuvants
    • 5.8.1. Global Vaccine Adjuvants Market, by Bacteria-derived Adjuvants, by Region, 2016- 2027 (USD Million)
  • 5.9. Virus-like Particles (VLP)
    • 5.9.1. Global Vaccine Adjuvants Market, by Virus-like Particles (VLP), by Region, 2016- 2027 (USD Million)
  • 5.10. Other Types
    • 5.10.1. Global Vaccine Adjuvants Market, by Other Types, by Region, 2016- 2027 (USD Million)

6. Global Vaccine Adjuvants Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • 6.3. Oral
    • 6.3.1. Global Vaccine Adjuvants Market, by Oral, By Region, 2016- 2027 (USD Million)
  • 6.4. Subcutaneous
    • 6.4.1. Global Vaccine Adjuvants Market, by subcutaneous, by Region, 2016- 2027 (USD Million)
  • 6.5. Intranasal
    • 6.5.1. Global Vaccine Adjuvants Market, by Intranasal, by Region, 2016- 2027 (USD Million)
  • 6.6. Intramuscular
    • 6.6.1. Global Vaccine Adjuvants Market, by Intramuscular, by Region, 2016- 2027 (USD Million)
  • 6.7. Intradermal
    • 6.7.1. Global Vaccine Adjuvants Market, by Intradermal, by Region, 2016- 2027 (USD Million)
  • 6.8. Others
    • 6.8.1. Global Vaccine Adjuvants Market, by Others, by Region, 2016- 2027 (USD Million)

7. Global Vaccine Adjuvants Market, by Disease Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • 7.3. Infectious Diseases
    • 7.3.1. Global Vaccine Adjuvants Market, by Infectious Diseases, By Region, 2016- 2027 (USD Million)
  • 7.4. Rare Diseases
    • 7.4.1. Global Vaccine Adjuvants Market, by Rare Diseases, by Region, 2016- 2027 (USD Million)
  • 7.5. Cancer
    • 7.5.1. Global Vaccine Adjuvants Market, by Cancer, by Region, 2016- 2027 (USD Million)
  • 7.6. Autoimmune Disorders
    • 7.6.1. Global Vaccine Adjuvants Market, by Autoimmune Disorders, by Region, 2016- 2027 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Vaccine Adjuvants Market, by Others, by Region, 2016- 2027 (USD Million)

8. Vaccine Adjuvants Market Assessment by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • 8.3. Research Application
    • 8.3.1. Global Vaccine Adjuvants Market, by Research Application, by Region, 2016- 2027 (USD Million)
  • 8.4. Commercial Application
    • 8.4.1. Global Vaccine Adjuvants Market, by Commercial Application, by Region, 2016- 2027 (USD Million)

9. Vaccine Adjuvants Market Assessment by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Vaccine Adjuvants Market Assessment, By Geography, 2016- 2027 (USD Million)
  • 9.3. Vaccine Adjuvants Market - North America
    • 9.3.1. North America: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
    • 9.3.2. North America: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
    • 9.3.3. North America: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
    • 9.3.4. North America: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.3.5. Vaccine Adjuvants Market - U.S.
      • 9.3.5.1. U.S.: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.3.5.2. U.S.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.3.5.3. U.S.: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.3.5.4. U.S.: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.3.6. Vaccine Adjuvants Market - Canada
      • 9.3.6.1. Canada: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.3.6.2. Canada.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.3.6.3. Canada: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.3.6.4. Canada: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
  • 9.4. Vaccine Adjuvants Market - Europe
    • 9.4.1. Europe: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
    • 9.4.2. Europe.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
    • 9.4.3. Europe: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.4.4. Europe: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.4.5. Vaccine Adjuvants Market - UK
      • 9.4.5.1. UK: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.5.2. UK.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.4.5.3. UK: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.5.4. UK: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.4.6. Vaccine Adjuvants Market - France
      • 9.4.6.1. France: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.6.2. France.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.4.6.3. France: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.6.4. France: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.4.7. Vaccine Adjuvants Market - Germany
      • 9.4.7.1. Germany: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.7.2. Germany.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.4.7.3. Germany: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.7.4. Germany: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.4.8. Vaccine Adjuvants Market - Italy
      • 9.4.8.1. Italy: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.8.2. Italy.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.4.8.3. Italy: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.8.4. Italy: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.4.9. Vaccine Adjuvants Market - Spain
      • 9.4.9.1. Spain: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.9.2. Spain.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.4.9.3. Spain: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.9.4. Spain: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.4.10. Vaccine Adjuvants Market - Belgium
      • 9.4.10.1. Belgium: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.10.2. Belgium.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.4.10.3. Belgium: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.10.4. Belgium: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.4.11. Vaccine Adjuvants Market - Austria
      • 9.4.11.1. Austria: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.11.2. Austria.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.4.11.3. Austria: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.4.11.4. Austria: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
  • 9.5. Vaccine Adjuvants Market - Asia-Pacific
    • 9.5.1. Asia Pacific: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
    • 9.5.2. Asia Pacific.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
    • 9.5.3. Asia-pacific: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.5.4. Asia-pacific: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.5.5. Vaccine Adjuvants Market - China
      • 9.5.5.1. China: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.5.2. China.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.5.5.3. China: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.5.4. China: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.5.6. Vaccine Adjuvants Market - India
      • 9.5.6.1. India: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.6.2. India.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.5.6.3. India: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.6.4. India: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.5.7. Vaccine Adjuvants Market - Malaysia
      • 9.5.7.1. Malaysia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.7.2. Malaysia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.5.7.3. Malaysia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.7.4. Malaysia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.5.8. Vaccine Adjuvants Market - Japan
      • 9.5.8.1. Japan: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.8.2. Japan.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.5.8.3. Japan: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.8.4. Japan: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.5.9. Vaccine Adjuvants Market - South Korea
      • 9.5.9.1. South Korea: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.9.2. South Korea.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.5.9.3. South Korea: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.9.4. South Korea: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.5.10. Vaccine Adjuvants Market - Australia
      • 9.5.10.1. Australia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.10.2. Australia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.5.10.3. Australia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.5.10.4. Australia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
  • 9.6. Vaccine Adjuvants Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
    • 9.6.2. Middle East & Africa.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
    • 9.6.3. Middle East & Africa: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.6.4. Middle East & Africa: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.6.5. Vaccine Adjuvants Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.6.5.2. Saudi Arabia.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.6.5.3. Saudi Arabia: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.6.5.4. Saudi Arabia: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.6.6. Vaccine Adjuvants Market - UAE
      • 9.6.6.1. UAE: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.6.6.2. UAE.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.6.6.3. UAE: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.6.6.4. UAE: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.6.7. Vaccine Adjuvants Market - Israel
      • 9.6.7.1. Israel: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.6.7.2. Israel.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.6.7.3. Israel: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.6.7.4. Israel: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.6.8. Vaccine Adjuvants Market - South Africa
      • 9.6.8.1. South Africa: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.6.8.2. South Africa.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.6.8.3. South Africa: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.6.8.4. South Africa: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
  • 9.7. Vaccine Adjuvants Market - Latin America
    • 9.7.1. Latin America: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
    • 9.7.2. Latin America.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
    • 9.7.3. Latin America: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
    • 9.7.4. Latin America: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.7.5. Vaccine Adjuvants Market - Mexico
      • 9.7.5.1. Mexico: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.7.5.2. Mexico.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.7.5.3. Mexico: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.7.5.4. Mexico: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.7.6. Vaccine Adjuvants Market - Brazil
      • 9.7.6.1. Brazil: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.7.6.2. Brazil.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.7.6.3. Brazil: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.7.6.4. Brazil: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)
    • 9.7.7. Vaccine Adjuvants Market - Argentina
      • 9.7.7.1. Argentina: Vaccine Adjuvants Market, By Product Type, 2016- 2027 (USD Million)
      • 9.7.7.2. Argentina.: Vaccine Adjuvants Market, By Route of Administration, 2016- 2027 (USD Million)
      • 9.7.7.3. Argentina: Vaccine Adjuvants Market, By Disease Type, 2016- 2027 (USD Million)
      • 9.7.7.4. Argentina: Vaccine Adjuvants Market, By Application, 2016- 2027 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. GlaxoSmithKline Plc
    • 11.1.1. Company Overview
    • 11.1.2. Product Benchmarking
    • 11.1.3. Financial Performance
    • 11.1.4. Recent Development
  • 11.2. Moderna Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Product Benchmarking
    • 11.2.3. Financial Performance
    • 11.2.4. Recent Development
  • 11.3. Sanofi Pasteur
    • 11.3.1. Company Overview
    • 11.3.2. Product Benchmarking
    • 11.3.3. Financial Performance
    • 11.3.4. Recent Development
  • 11.4. Adjuvatis
    • 11.4.1. Company Overview
    • 11.4.2. Product Benchmarking
    • 11.4.3. Financial Performance
    • 11.4.4. Recent Development
  • 11.5. SPI Pharma
    • 11.5.1. Company Overview
    • 11.5.2. Product Benchmarking
    • 11.5.3. Financial Performance
    • 11.5.4. Recent Development
  • 11.6. Novavax, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Product Benchmarking
    • 11.6.3. Financial Performance
    • 11.6.4. Recent Development
  • 11.7. Sergeant Adjuvants
    • 11.7.1. Company Overview
    • 11.7.2. Product Benchmarking
    • 11.7.3. Financial Performance
    • 11.7.4. Recent Development
  • 11.8. OZ Biosciences
    • 11.8.1. Company Overview
    • 11.8.2. Product Benchmarking
    • 11.8.3. Financial Performance
    • 11.8.4. Recent Development
  • 11.9. Adjuvants Euclid Canada Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Product Benchmarking
    • 11.9.3. Financial Performance
    • 11.9.4. Recent Development
  • 11.10. Adjuvants Unlimited Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Product Benchmarking
    • 11.10.3. Financial Performance
    • 11.10.4. Recent Development
  • 11.11. Aphios Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Product Benchmarking
    • 11.11.3. Financial Performance
    • 11.11.4. Recent Development

List of Tables

  • Table 1 Global Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 2 Global Vaccine Adjuvants Market, by Route of Administration, by Region, 2016 - 2027 (USD Million)
  • Table 3 Global Vaccine Adjuvants Market, by Disease Type, by Region, 2016 - 2027 (USD Million)
  • Table 4 Global Vaccine Adjuvants Market, by Application, by Region, 2016 - 2027 (USD Million)
  • Table 5 Vaccine Adjuvants Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Table 6 North America: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 7 North America: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 8 North America: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 9 North America: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 10 U.S.: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 11 U.S.: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 12 U.S.: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 13 U.S.: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 14 Canada: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 15 Canada: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 16 Canada: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 17 Canada: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 18 Europe: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 19 Europe: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 20 Europe: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 21 Europe: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 22 UK: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 23 UK: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 24 UK: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 25 UK: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 26 France: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 27 France: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 28 France: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 29 France: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 30 Germany: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 31 Germany: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 32 Germany: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 33 Germany: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 34 Italy: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 35 Italy: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 36 Italy: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 37 Italy: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 38 Belgium: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 39 Belgium: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 40 Belgium: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 41 Belgium: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 42 Austria: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 43 Austria: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 44 Austria: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 45 Austria: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 46 Asia Pacific: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 47 Asia Pacific: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 48 Asia Pacific: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 49 Asia Pacific: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 50 China: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 51 China: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 52 China: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 53 China: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 54 India: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 55 India: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 56 India: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 57 India: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 58 Japan: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 59 Japan: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 60 Japan: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 61 Japan: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 62 Malaysia: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 63 Malaysia: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 64 Malaysia: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 65 Malaysia: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 66 South Korea: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 67 South Korea: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 68 South Korea: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 69 South Korea: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 70 Australia: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 71 Australia: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 72 Australia: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 73 Australia: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 74 Middle East & Africa: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 75 Middle East & Africa: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 76 Middle East & Africa: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 77 Middle East & Africa: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 78 Saudi Arabia: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 79 Saudi Arabia: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 80 Saudi Arabia: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 81 Saudi Arabia: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 82 Israel: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 83 Israel: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 84 Israel: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 85 Israel: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 86 South Africa: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 87 South Africa: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 88 South Africa: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 89 South Africa: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 90 Latin America: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 91 Latin America: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 92 Latin America: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 93 Latin America: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 94 Brazil: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 95 Brazil: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 96 Brazil: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 97 Brazil: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 98 Mexico: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 99 Mexico: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 100 Mexico: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 101 Mexico: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)
  • Table 102 Argentina: Vaccine Adjuvants Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 103 Argentina: Vaccine Adjuvants Market, By Route of Administration, 2016 - 2027 (USD Million)
  • Table 104 Argentina: Vaccine Adjuvants Market, By Disease Type, 2016 - 2027 (USD Million)
  • Table 105 Argentina: Vaccine Adjuvants Market, By Application, 2016 - 2027 (USD Million)

List of Figures

  • Figure 1. Market Highlights (2019, Revenue)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top Down & Bottom Up Approach
  • Figure 4. Market by Geography
  • Figure 6. Porter's Five Forces
  • Figure 7. Market by Product Type
  • Figure 8. Global Vaccine Adjuvants Market, By Product Type, 2019 & 2027 (USD Million)
  • Figure 9. Market by Route of Administration
  • Figure 8. Global Vaccine Adjuvants Market, By Route of Administration, 2019 & 2027 (USD Million)
  • Figure 9. Market by Disease Type
  • Figure 10. Global Vaccine Adjuvants Market, By Disease Type, 2019 & 2027 (USD Million)
  • Figure 11. Market by Application
  • Figure 12. Global Vaccine Adjuvants Market, By Application, 2019 & 2027 (USD Million)
  • Figure 13. Vaccine Adjuvants Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Figure 14. Strategic Analysis - Vaccine Adjuvants Market